Stay updated on Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a CMS backend update. This update does not modify the displayed study details or participant information.SummaryDifference0.0%

- Check15 days agoChange DetectedA new Revision: v3.6.2 label was added, replacing the previous Revision: v3.6.0. This reflects a small technical update to the page rather than any change to the study details.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page now explicitly notes that the study is no longer recruiting participants, aligning with the Active, not recruiting status and informing potential participants. New user guidance sections have been added (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment heading formatting has been adjusted, and the revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check37 days agoChange DetectedA new page revision label Revision: v3.5.5 was added, replacing the previous Revision: v3.5.4; this indicates a minor update to the page version without affecting study details.SummaryDifference0.0%

- Check58 days agoChange DetectedA new site revision label Revision: v3.5.4 was added, and the previous label Revision: v3.5.3 was removed. This reflects a minor platform update rather than a change to study content.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page’s displayed software/theme revision was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.